Immediate Impact

2 from Science/Nature 67 standout
Sub-graph 1 of 23

Citing Papers

Tumor-targeted delivery of a STING agonist improves cancer immunotherapy
2022 Standout
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
2021 Standout
2 intermediate papers

Works of F Latteri being referenced

Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib (‘Iressa’, ZD1839) in non-small-cell lung cancer
2004
Activity of a specific inhibitor, gefitinib (Iressa™, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer
2003

Author Peers

Author Last Decade Papers Cites
F Latteri 177 230 206 27 409
Yoshio Kadokawa 165 182 111 34 422
Francesca Bazzocchi 209 231 182 31 421
Vincent Falck 205 100 193 26 454
Rajkumar Vajpeyi 234 119 232 29 445
Naomi Katsuki 146 167 102 29 384
Ioannis Kyriazanos 239 134 77 26 423
U. Pohlen 180 110 189 31 395
Masaaki Inomata 204 189 162 19 457
Che‐Jen Huang 262 90 143 33 424
Abdullah Zorluoğlu 157 77 117 29 376

All Works

Loading papers...

Rankless by CCL
2026